<i>GFAP</i> mutations, age at onset, and clinical subtypes in Alexander disease
Morgan J. Prust(Coriell Institute For Medical Research), Adeline Vanderver(Children's Hospital of Philadelphia), Michael Brenner(Coriell Institute For Medical Research), Jon L. Fleming(Coriell Institute For Medical Research), Heidi A. Heilstedt(Coriell Institute For Medical Research), Deepak Gill(Coriell Institute For Medical Research), Alyssa Reddy, T. Hartka(Coriell Institute For Medical Research), Hiroki Morizono(Coriell Institute For Medical Research), Martina Schneider(Valneva (Austria)), Jiaxian Wang(Coriell Institute For Medical Research), Martin Griebel(Coriell Institute For Medical Research), K Wakabayashi(Coriell Institute For Medical Research), Argirios Dinopoulos(Coriell Institute For Medical Research), Yoshihisa Takiyama(Coriell Institute For Medical Research), Edgar Gordon(Coriell Institute For Medical Research), Alexander Sokohl(Coriell Institute For Medical Research), Elliott H. Sherr(Neurosciences Institute), Albee Messing(University of Wisconsin–Madison), Heather Gordish‐Dressman(Coriell Institute For Medical Research), Maria Teresa Dotti(Coriell Institute For Medical Research), Daniel Fain(Coriell Institute For Medical Research), Yukio Sawaishi(Coriell Institute For Medical Research), M. Nakagawa(Coriell Institute For Medical Research), P A Kaplan(Coriell Institute For Medical Research), R.C. Pedersen(Coriell Institute For Medical Research), J. R. Gorospe(Coriell Institute For Medical Research), D. Lewis(Coriell Institute For Medical Research), Kathrin Brockman(Coriell Institute For Medical Research), Hernán Amartino(Manchester Royal Eye Hospital), J Ferreira(Coriell Institute For Medical Research), Raphael Schiffmann(Baylor Scott & White Health), Ricardo Suárez Fernández(Coriell Institute For Medical Research), Roger L. Albin(VA Ann Arbor Healthcare System)
Cited by 256
Related Papers
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
|Journal of Clinical Oncology|2016|867
Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy
|New England Journal of Medicine|2017|592
Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat
|New England Journal of Medicine|2016|555
Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy
|Nephrology Dialysis Transplantation|2009|366